1. Market Research
  2. > Healthcare
  3. > Health Services Market Trends
Global Atherectomy Devices Market (2019-2025)

Global Atherectomy Devices Market (2019-2025)

  • September 2019
  • 122 pages
  • ID: 5823321
  • Format: PDF
  • KBV Research

Summary

Table of Contents

The Global Atherectomy Devices Market size is expected to reach $900.7 million by 2025, rising at a market growth of 6.8% CAGR during the forecast period (2019-2025). The atherectomy procedure has been recognized as a minimally invasive surgical technique to remove atherosclerosis from blood vessels in the human body. This surgical procedure is a great replacement to angioplasty for treating peripheral artery disease. However, there are not enough studies to determine atherectomy’s superiority of angioplasty. It is also used for the treatment of coronary artery disease.

Atherectomy devices have been developed to allow the site of coronary occlusion or stenosis to drill, grind or sand atheroma, calcium, and excess cellular material. Mechanical approaches and laser-based methods are used extensively. To remove plaque from coronary arteries, the rotational atherectomy catheter (Rotablator) is engineered.

The key market players actively involved in the atherectomy devices market include Boston Scientific Corporation, Medtronic (Covidien), Cardiovascular Systems Inc., Spectranetics, Avinger Inc., Volcano Corporation, Koninklijke Philips N.V, ST. Jude Medical, Straub Medical AG, Cardinal Health (Cordis), BARD Peripheral Vascular, and Terumo IS. Market players are taking step-by-step approaches to leverage business possibilities. Companies focus on creative market-space competitive initiatives.

For example, in July 2018, Cardiovascular Systems signed an agreement with OrbusNeich for selling its coronary and peripheral Orbital Atherectomy Systems (OAS) in other countries. In the same month, the company collaborated with Aerolase Corporation for developing a new laser atherectomy device for physicians which can be used more effectively in the treatment of multiple forms of arterial disease.

In December 2015, Medtronic acquired Covidien to enhance its business in developing Atherectomy Device. In June 2017, Koninklijke Philips N.V. took over Spectranetics for expansion of image-guided therapy business group.

In March 2018, Terumo Corporation acquired assets related to the large bore vascular closure device from Medeon Biodesign, Inc. for enhancement of its product portfolio. In January 2019, Terumo IS expanded its reach to Canada by opening a new office in Vaughan, Ontario focusing on the expansion of its business.

The increased prevalence of target diseases is the major influential factor of the market. Over 250 million people across the globe suffer from peripheral artery disease (PAD), with an escalating geriatric population. Between 2000 and 2010, the incidence of PAD rose by 24% and continues to develop at an accelerating pace. This incidence is present in both high-and low-income nations. Low-income countries have seen a 29 percent raise, while high-income countries have seen a 13 percent raise over the past century.

Based on Type, the market is segmented into Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy and Laser Atherectomy. Based on Regions, the market is segmented into North America, Europe, Asia Pacific, and Latin America, Middle East & Africa.

Recent strategies deployed in Atherectomy Devices Market

Collaborations, Partnerships and Agreements:

Jul-2018: Cardiovascular Systems has collaborated with Aerolase Corporation for developing a new laser atherectomy device for physicians which can be used more effectively in the treatment of multiple form of arterial disease.

Jul-2018: Cardiovascular Systems has signed an agreement with OrbusNeich for selling its coronary and peripheral Orbital Atherectomy Systems (OAS) in other countries.

Nov-2016: Cardiovascular Systems has announced an agreement with Medikit Co., Ltd. in order to sell its Diamondback 360® Coronary and Peripheral Orbital Atherectomy Systems (OAS) in Japan.

Acquisition and Mergers:

Aug-2019: Cardiovascular Systems has acquired WIRION Embolic Protection System and related assets from Gardia Medical Ltd., a wholly owned Israeli subsidiary of Allium Medical Solutions Ltd. for use in any atherectomy system.

Aug-2019: Boston acquired BTG in order to develop products for vascular diseases.

Jan-2019: Abbott acquired Cephea Valve in order to expand the device portfolio to use in valve diseases.

Mar-2018: Terumo has acquired assets related to the large bore vascular closure device from Medeon Biodesign, Inc. for enhancement of its product portfolio.

Jun-2017: Philips has taken over Spectranetics for expansion of image-guided therapy business group.

Jan-2017: Abbott took over St. Jude Medical for expanding the product portfolio for treating the patients efficiently.

Dec-2015: Medtronic has acquired Covidien in order to enhance its business in developing Atherectomy Device.

Product launches:

Jul-2019: Avinger has launched Ocelot, image-guided chronic total occlusion (CTO) crossing system use in treatment of artery diseases.

Oct-2016: Avinger has introduced Lightbox Imaging Consolefirst-ever image-guided atherectomy and chronic total occlusion (CTO) recanalization devices for the treatment of artery diseases.

Scope of the Study

Market Segmentation:

By Type

• Directional Atherectomy

• Rotational Atherectomy

• Orbital Atherectomy and

• Laser Atherectomy

By Geography

• North America

o US

o Canada

o Mexico

o Rest of North America

• Europe

o Germany

o UK

o France

o Russia

o Spain

o Italy

o Rest of Europe

• Asia Pacific

o China

o India

o Japan

o South Korea

o Singapore

o Malaysia

o Rest of Asia Pacific

• LAMEA

o Brazil

o Argentina

o UAE

o Saudi Arabia

o South Africa

o Nigeria

o Rest of LAMEA

Companies Profiled

• Cardiovascular Systems, Inc.

• Avinger, Inc.

• Straub Medical AG

• Boston Scientific Corporation

• Medtronic PLC (Covidien)

• Koninklijke Philips N.V.

• Cardinal Health, Inc. (Cordis)

• Terumo Corporation (Terumo IS)

• Abbott Laboratories

• B. Braun Melsungen AG

Unique Offerings from KBV Research

• Exhaustive coverage

• Highest number of market tables and figures

• Subscription based model available

• Guaranteed best price

• Assured post sales research support with 10% customization free

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

United States Interventional Cardiology Procedures Outlook to 2025 - Angiography Procedures, Balloon Angioplasty Procedures, Coronary Stenting Procedures and Others

  • $ 2995
  • October 2020
  • 19 pages

United States Interventional Cardiology Procedures Outlook to 2025 - Angiography Procedures, Balloon Angioplasty Procedures, Coronary Stenting Procedures and Others Summary “United States Interventional ...

  • United States
  • North America
  • Cardiovascular Devices
  • Cardiology
  • Industry analysis

ref:plp2019

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on